Bonraybio Co. Ltd. (6955) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Bonraybio Co. Ltd. (6955:TWSE), powered by AI.

Current Price
$147.50
P/E Ratio
113.2
Market Cap
2.9B
Sector
Healthcare
What is the Bonraybio Co. Ltd. stock price forecast?

Bonraybio Co. Ltd. is currently trading at $147.50. View real-time AI analysis on Alpha Lenz.

What is Bonraybio Co. Ltd. insider trading activity?

View the latest insider trading data for Bonraybio Co. Ltd. on Alpha Lenz.

What is Bonraybio Co. Ltd.'s P/E ratio?

Bonraybio Co. Ltd.'s P/E ratio is 113.2.

Bonraybio Co. Ltd.

TWSE · 6955
NT$147.50+0.00(+0.00%)
Ask about Bonraybio Co. Ltd.'s future dividend policy...
Alpha Chat Insight

Bonraybio Co. Ltd. trades at a P/E of 113.2 (premium valuation) with solid ROE of 9.7%.

Ask for details

Company Overview

Bonraybio Co. Ltd. is a prominent biotechnology company primarily engaged in the development and commercialization of advanced diagnostic solutions. Its core focus is on the creation of sophisticated diagnostic tests and systems that address a variety of health conditions. This company operates within the healthcare and life sciences sector, often at the forefront of innovative diagnostic research that aids in early detection and management of diseases. Bonraybio’s solutions contribute significantly to areas like oncology, infectious diseases, and personalized medicine, enabling more precise and timely patient care. By leveraging cutting-edge technologies, Bonraybio plays a crucial role in enhancing diagnostic accuracy and efficiency, ultimately contributing to improved healthcare outcomes. The company's presence in the bio-diagnostics market underscores its commitment to advancing scientific knowledge and supporting the global healthcare infrastructure through reliable and accessible diagnostic tools.

SectorHealthcare
IndustryMedical Devices
0

Company Statistics

FY 2023

Profile

NT$2.91BMarket Cap
NT$159.64MRevenue
0.00Shares Out
0Employees

Margins

75.04%Gross
22.93%EBITDA
13.37%Operating
16.13%Pre-Tax
16.11%Net

Valuation

113.15P/E
10.45P/B
18.23EV/Sales
76.68EV/EBITDA
169.79P/FCF

Growth (CAGR)

N/ARev 3Yr
N/ARev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

8.61%ROA
9.68%ROE
8.70%ROIC

Financial Health

NT$116.87MCash & Cash Equivalents
NT$-78.07MNet Debt
13.94%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Bonraybio Co. Ltd. (ticker: 6955) is a company listed on TWSE in the Healthcare sector (Medical Devices). Market cap is $2.9B.

The current price is 147.5 with a P/E ratio of 113.15x and P/B of 10.45x.

ROE is 9.68% and operating margin is 13.37%. Annual revenue is $160M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Bonraybio Co. Ltd. (6955) Stock Forecast 2026 $147.50 — Price, Financials & Analyst Targets | Alpha Lenz